{"SPADE_UN_30291": {"Sequence Information": {"Peptide Name": "Tritrpticin [W 6,7,8 5-OH-W]", "Sequence": "VRRFPXXXPFLRR", "Sequence Length": 13, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "P51524", "uniprotUrl": "http://www.uniprot.org/uniprot/P51524", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."}], "Literature": [{"Title": "Hydroxy-tryptophan containing derivatives of tritrpticin: modification of antimicrobial activity and membrane interactions.", "Pubmed ID": "25178967", "Reference": "Biochim Biophys Acta. 2015;1848:277-288", "Author": "Arias M, Jensen KV, Nguyen LT, Storey DG, Vogel HJ", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/25178967"}, {"Title": "Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin.", "Pubmed ID": "32126228", "Reference": "Biochim Biophys Acta. 2020;1862:183228", "Author": "Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/32126228"}], "SPADE ID": "SPADE_UN_30291", "Similar Sequences": [{"SPADE_ID": "SPADE_N_02575", "Similarity": 1.0, "Sequence": "VRRFPWWWPFLRR"}, {"SPADE_ID": "SPADE_N_04440", "Similarity": 1.0, "Sequence": "QRAKTPQTRVTIRTVRVRRPP"}, {"SPADE_ID": "SPADE_N_06502", "Similarity": 1.0, "Sequence": "VRRFPWWPFLRR"}], "Hemolytic Activity": "Human PBMC:IC50=>=65 µM,Human erythrocytes:50% Hemolysis=>=65 µM", "Target Organism": "Escherichia coli ATCC 25922(MIC=4-8µM),Escherichia coli ATCC 25922(MBC=4-8µM),Bacillus subtilis 168(MIC=0.5-1µM),Bacillus subtilis 168(MBC=0.5-1µM),Jurkat T-cell leukemia(IC50=44.8µM)"}}}